Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 33 studies | 30% ± 15% | |
macrophage | 12 studies | 26% ± 10% | |
connective tissue cell | 8 studies | 37% ± 12% | |
pericyte | 6 studies | 29% ± 8% | |
endothelial cell | 5 studies | 23% ± 9% | |
myofibroblast cell | 5 studies | 30% ± 8% | |
myeloid cell | 5 studies | 26% ± 8% | |
epithelial cell | 5 studies | 26% ± 8% | |
smooth muscle cell | 4 studies | 22% ± 9% | |
adventitial cell | 4 studies | 20% ± 4% | |
basal cell | 4 studies | 21% ± 5% | |
secretory cell | 3 studies | 18% ± 2% | |
monocyte | 3 studies | 20% ± 5% | |
ciliated cell | 3 studies | 19% ± 1% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 4 studies | 22% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
skin | 100% | 32327.22 | 1809 / 1809 | 100% | 770.56 | 471 / 472 |
esophagus | 100% | 14398.02 | 1444 / 1445 | 97% | 274.05 | 178 / 183 |
uterus | 100% | 25724.46 | 170 / 170 | 97% | 438.49 | 443 / 459 |
bladder | 100% | 18933.43 | 21 / 21 | 96% | 357.01 | 486 / 504 |
breast | 100% | 19746.17 | 459 / 459 | 96% | 391.29 | 1072 / 1118 |
lung | 100% | 17179.01 | 577 / 578 | 95% | 305.46 | 1098 / 1155 |
intestine | 100% | 13665.31 | 965 / 966 | 94% | 240.63 | 493 / 527 |
stomach | 94% | 8803.77 | 337 / 359 | 94% | 225.69 | 270 / 286 |
thymus | 100% | 9978.95 | 650 / 653 | 80% | 137.12 | 485 / 605 |
ovary | 100% | 16203.49 | 180 / 180 | 73% | 153.09 | 316 / 430 |
kidney | 84% | 5811.58 | 75 / 89 | 87% | 205.35 | 782 / 901 |
pancreas | 64% | 3220.32 | 209 / 328 | 96% | 563.54 | 171 / 178 |
prostate | 100% | 11606.40 | 245 / 245 | 48% | 47.78 | 242 / 502 |
adrenal gland | 86% | 5453.92 | 222 / 258 | 24% | 50.07 | 56 / 230 |
adipose | 100% | 23796.76 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 428.51 | 80 / 80 |
ureter | 0% | 0 | 0 / 0 | 100% | 64.02 | 1 / 1 |
blood vessel | 100% | 20131.27 | 1334 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 368.17 | 44 / 45 |
spleen | 94% | 5573.86 | 227 / 241 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 69% | 160.05 | 20 / 29 |
heart | 61% | 3476.07 | 526 / 861 | 0% | 0 | 0 / 0 |
brain | 2% | 70.34 | 42 / 2642 | 42% | 83.58 | 299 / 705 |
liver | 7% | 321.81 | 16 / 226 | 33% | 71.79 | 132 / 406 |
muscle | 21% | 995.50 | 169 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 21.72 | 4 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0043615 | Biological process | astrocyte cell migration |
GO_0048870 | Biological process | cell motility |
GO_0001525 | Biological process | angiogenesis |
GO_1905523 | Biological process | positive regulation of macrophage migration |
GO_1990834 | Biological process | response to odorant |
GO_0030324 | Biological process | lung development |
GO_0060322 | Biological process | head development |
GO_0043627 | Biological process | response to estrogen |
GO_0030307 | Biological process | positive regulation of cell growth |
GO_0048754 | Biological process | branching morphogenesis of an epithelial tube |
GO_0160145 | Biological process | negative regulation of GDF15-GFRAL signaling pathway |
GO_0001541 | Biological process | ovarian follicle development |
GO_0035988 | Biological process | chondrocyte proliferation |
GO_0035987 | Biological process | endodermal cell differentiation |
GO_0016485 | Biological process | protein processing |
GO_0014070 | Biological process | response to organic cyclic compound |
GO_0030198 | Biological process | extracellular matrix organization |
GO_0022617 | Biological process | extracellular matrix disassembly |
GO_0051895 | Biological process | negative regulation of focal adhesion assembly |
GO_0001958 | Biological process | endochondral ossification |
GO_0045579 | Biological process | positive regulation of B cell differentiation |
GO_0030574 | Biological process | collagen catabolic process |
GO_0010831 | Biological process | positive regulation of myotube differentiation |
GO_0031638 | Biological process | zymogen activation |
GO_0048771 | Biological process | tissue remodeling |
GO_0030335 | Biological process | positive regulation of cell migration |
GO_0001666 | Biological process | response to hypoxia |
GO_0001935 | Biological process | endothelial cell proliferation |
GO_0006508 | Biological process | proteolysis |
GO_0010954 | Biological process | positive regulation of protein processing |
GO_0030163 | Biological process | protein catabolic process |
GO_0048701 | Biological process | embryonic cranial skeleton morphogenesis |
GO_0008584 | Biological process | male gonad development |
GO_0001501 | Biological process | skeletal system development |
GO_0097094 | Biological process | craniofacial suture morphogenesis |
GO_0009612 | Biological process | response to mechanical stimulus |
GO_1903076 | Biological process | regulation of protein localization to plasma membrane |
GO_0045746 | Biological process | negative regulation of Notch signaling pathway |
GO_0006979 | Biological process | response to oxidative stress |
GO_0005615 | Cellular component | extracellular space |
GO_0005886 | Cellular component | plasma membrane |
GO_0031410 | Cellular component | cytoplasmic vesicle |
GO_0044354 | Cellular component | macropinosome |
GO_0005796 | Cellular component | Golgi lumen |
GO_0031012 | Cellular component | extracellular matrix |
GO_0005925 | Cellular component | focal adhesion |
GO_0045111 | Cellular component | intermediate filament cytoskeleton |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0042470 | Cellular component | melanosome |
GO_0005634 | Cellular component | nucleus |
GO_0004175 | Molecular function | endopeptidase activity |
GO_0070006 | Molecular function | metalloaminopeptidase activity |
GO_0005178 | Molecular function | integrin binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0004222 | Molecular function | metalloendopeptidase activity |
GO_0005515 | Molecular function | protein binding |
GO_0004252 | Molecular function | serine-type endopeptidase activity |
Gene name | MMP14 |
Protein name | Matrix metallopeptidase 14 Matrix metalloproteinase-14 (EC 3.4.24.80) Matrix metalloproteinase-14 (MMP-14) (EC 3.4.24.80) (MMP-X1) (Membrane-type matrix metalloproteinase 1) (MT-MMP 1) (MTMMP1) (Membrane-type-1 matrix metalloproteinase) (MT1-MMP) (MT1MMP) |
Synonyms | |
Description | FUNCTION: Endopeptidase that degrades various components of the extracellular matrix such as collagen. Activates progelatinase A. Essential for pericellular collagenolysis and modeling of skeletal and extraskeletal connective tissues during development (By similarity). May be involved in actin cytoskeleton reorganization by cleaving PTK7 . Acts as a positive regulator of cell growth and migration via activation of MMP15. Involved in the formation of the fibrovascular tissues in association with pro-MMP2 . Cleaves ADGRB1 to release vasculostatin-40 which inhibits angiogenesis . . |
Accessions | ENST00000547279.1 ENST00000680097.1 ENST00000311852.11 A0A7P0TAG0 F8VP90 ENST00000680941.1 A0A7P0TAV6 ENST00000548162.2 A0A7P0TBK8 P50281 K4RH61 |